Home › Follicular Lymphoma › Illinois › Chicago

Pag-aaral pangklinika para sa Follicular Lymphoma sa Chicago, IL

Isang pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Nagre-recruitPhase 3

University of Illinois, Chicago

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215910

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

The University of Chicago Medical Center (UCMC), Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Nagre-recruitPhase 1/2

Northwestern Memorial Hospital, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05765812

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Nagre-recruitPhase 1

Northwestern University, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

University of Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Nagre-recruitPhase 2

Ruth M. Rothstein CORE Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06651177

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Northwestern University, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Nagre-recruitPhase 1/2

University of Illinois at Chicago Cancer Center, Chicago

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

The University of Chicago Medical Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

Northwestern Memorial Hospital, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chicago

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Follicular Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.